CD8A and viral infectious disease: Recent studies in mice have shown that blocking the IL-10 signaling pathway facilitates clearance of chronic viral infections [36], [37], and in vitro studies in PBMC from HIV-infected subjects have extended these findings to indicate that HIV-specific CD4+ and CD8+ T-cell responses are also augmented by antibodies that interrupt the IL-10/IL-10-receptor interaction [38].